N/A
N=321
SMS Mobile Technology for Vaccine Coverage and Acceptance
Adherence to Vaccination Schedules
Bottom Line
View on ClinicalTrials.gov: NCT01663636 ↗Enrolled (actual)
321
Serious AEs
0.0%
Results posted
Dec 2018
Primary outcome: Primary: Completion of 3 Doses of Pentavalent Vaccine — 135; 130 participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- SMS message reminding mothers to come for their scheduled vaccines (Behavioral)
- Age
- Pediatric · 0+ yrs
- Sex
- All
- Sponsor
- University of Colorado, Denver
- Primary completion
- Jun 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Completion of 3 Doses of Pentavalent Vaccine |
135; 130 | — |
Summary
To pilot test a mobile phone SMS (Short Message Service) system that will provide periodical messaging texts to mothers or custodians of infants who come for their first dose vaccines within the first 3 months of life to improve timely immunization coverage, vaccine acceptance and ensure vaccine safety monitoring. The intervention will include a "cloud-based" information system alimented by mobile phone data entry at the health post nurse level, that links child vaccination status and is able to remind parents and nurses of the need for next vaccination appointment and provide a system for reporting of adverse events following immunization in the immediate post-vaccination period.
Eligibility Criteria
Inclusion Criteria
- Infants 1-3 months of age coming for their 1 dose of primary vaccines
Exclusion Criteria
- Received 1 dose of vaccines, excluding BCG
- No mobile phone with SMS or unable to use SMS at home
- Intent to move from the clinic area in the next 6 months
Data sourced from ClinicalTrials.gov (NCT01663636). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.